Cronos Group (NASDAQ:CRON - Get Free Report) will issue its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Parties interested in participating in the company's conference call can do so using this link.
Cronos Group (NASDAQ:CRON - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.02) EPS for the quarter. Cronos Group had a negative net margin of 56.43% and a negative return on equity of 2.06%. The business had revenue of $27.76 million during the quarter, compared to analysts' expectations of $25.85 million. During the same quarter last year, the business posted ($0.02) earnings per share. On average, analysts expect Cronos Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cronos Group Stock Up 0.9 %
Shares of NASDAQ:CRON traded up $0.02 during trading on Tuesday, hitting $2.22. The stock had a trading volume of 1,735,627 shares, compared to its average volume of 1,925,375. The stock has a market capitalization of $848.71 million, a price-to-earnings ratio of -14.80 and a beta of 0.98. Cronos Group has a 12-month low of $1.83 and a 12-month high of $3.14. The stock has a 50-day simple moving average of $2.19 and a two-hundred day simple moving average of $2.37.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Stories
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.